Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug;85(2):287-298.
doi: 10.1016/j.jaad.2021.02.090. Epub 2021 Apr 20.

In vitro diagnostics for the medical dermatologist. Part I: Autoimmune tests

Affiliations
Review

In vitro diagnostics for the medical dermatologist. Part I: Autoimmune tests

Kelsey B Nusbaum et al. J Am Acad Dermatol. 2021 Aug.

Abstract

Despite the expansion of available in vitro laboratory tests at a rate far exceeding that of dermatologic pharmaceuticals, the existing literature is dominated by discussion of the latter. With the advent of numerous new tests, it can be difficult for practicing dermatologists to stay up-to-date on the available options, methodologies, and recommendations for when to order one test over another. Understanding the inherent strengths and weaknesses of these options is necessary to inform appropriate ordering and proper interpretation of the results. The first article in this continuing medical education series summarizes information on methodology, test characteristics, and limitations of several in vitro laboratory tests used for the work up of undifferentiated patients suspected of having dermatologic autoimmune diseases and it provides a general guide to ordering these tests.

Keywords: antineutrophil cytoplasmic antibody; antinuclear antibody; autoimmune; autoimmune blistering diseases; bullous pemphigoid; dermatitis herpetiformis; dermatomyositis; diagnostic testing; epidermolysis bullosa acquisita; inflammatory bowel disease; medical dermatology; pemphigus.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest None disclosed.